Chapter
Psychosomatic Medicine in the 21st Century: Understanding Mechanisms and Barriers to Utilization
Today and Tomorrow: Challenges and Opportunities
Communication with Patients Suffering from Serious Physical Illness
The Problem of Communication with Physically Ill Patients
Barriers to Communication in Medical Settings
Characteristics of Effective Communication
Specific Aspects Influencing Doctor-Patient Communication and Relationships
Training in Communication
Dimensional Psychopharmacology in Somatising Patients
Categorical versus Dimensional Approach
The Scale for the Rapid Assessment of Dimensional Psychopathology
Dimensional Psychopharmacology Approach to Somatic Symptom Disorders
Forensic Issues in Medical Evaluation: Competency and End-of-Life Issues
Ethical and Legal Principles
Principles of Capacity Assessment
Standardized Tests and Instruments
Overview of Options for Treating Incompetent Patients
Misconceptions and Pitfalls
Decision-Making Capacity at the End of Life
How Surrogates Make Decisions
Physicians’ Involvement in End-of-Life Decisions
Conflicts between Surrogates and Treatment Teams
Suggested Approach to Capacity Consultation
Then and Now … HIV Consultation Psychiatry Update
Substance Abuse Issues During Human Immunodeficiency Virus Infection
Cannabis Abuse and Human Immunodeficiency Virus
Opioid and Human Immunodeficiency Virus Epidemiology
3,4-Methylenedioxymethamphetamine and Club Drugs and Human Immunodeficiency Virus
New Guidelines for Human Immunodeficiency Virus Exposure
Hepatitis C and Human Immunodeficiency Virus Co-Infection: Updates
Drug-Drug Interactions in the Setting of Hepatitis C Virus Treatment
Updates in Human Immunodeficiency Virus-Associated Cognitive Disorders
Fibromyalgia and Chronic Fatigue: The Underlying Biology and Related Theoretical Issues
The Role of the Immune System and Its Implication in Chronic Fatigue Syndrome/ Fibromyalgia
Elevated Inflammatory Markers in Chronic Fatigue Syndrome/Fibromyalgia
Oxidative Stress and Mitochondrial Dysfunction in Chronic Fatigue Syndrome and Fibromyalgia
Hypothalamic-Pituitary-Adrenal Axis Abnormalities and Chronic Fatigue Syndrome/Fibromyalgia
Summary of Findings and Concluding Remarks
Acknowledgements and Conflicts of Interest
Fibromyalgia and Chronic Fatigue Syndrome: Management Issues
Additional Symptoms and Comorbidities
Pharmacological Approaches
Emerging Pharmacological Treatments
Nonpharmacological Management
Additional Symptoms and Comorbidities
Telomeres, Early-Life Stress and Mental Illness
Basic Concepts of Telomere Biology
Measurement of Telomere Length
Cross-Sectional versus Longitudinal Approaches in Studies of Telomere Length
Source Tissue and Telomere Length
Telomere Length and Dynamics in Somatic Diseases
Asthma and Pulmonary Disease
Telomeres in Somatic Diseases: Summary
Telomere Length and Dynamics in Psychiatric Conditions
Telomere Length and Dynamics with Psychosocial Stressors
Telomeres and Early-Life Stress
Potential Mechanisms Mediating Telomere Length in Early-Life Stress
Telomeres and Early-Life Stress: Methodological Issues
Effects of Therapeutic Stress Reduction on Telomeres
Coping with Losses, Grief, and Mourning in Prostate Cancer
Functional Losses after Prostate Cancer Treatment
Urinary Incontinence and Irritability
Losses in Advanced and Metastatic Prostate Cancer
Loss of Function due to Androgen Deprivation
The Impact of Advanced or Metastatic Cancer on Relationships
Theoretical Models of the Impact of Cancer on the Individual’s Psychology and on Couples’ Emotional and Sexual Intimacy
A Biopsychosocial Approach to the Care of Prostate Cancer Survivors
Physiologic Rehabilitation for the Side Effects of Localized Prostate Cancer Treatments
Physiologic Rehabilitation for the Side Effects of Advanced and Metastatic Prostate Cancer Treatments
Classification of Psychodermatologic Disorders
Primary Psychiatric Disorders
Secondary Psychiatric Disorders
Psychophysiologic Disorders
Cutaneous Sensory Disorders
Primary Psychiatric Disorders in Psychodermatology
Clinical Presentation and Diagnosis
Clinical Presentation and Diagnosis
Clinical Presentation and Diagnosis
Clinical Presentation and Diagnosis
Clinical Presentation and Diagnosis
Huntington’s Disease: Looking Beyond the Movement Disorder
Behavioral and Psychiatric Dysfunction
Joint Hypermobility, Anxiety and Psychosomatics: Two and a Half Decades of Progress Toward a New Phenotype
History of Link Joint Laxity – Anxiety
What is Joint Laxity (Hypermobility) Syndrome
The Diagnosis of Joint Hypermobility (Hyperlaxity)
Psychosomatic Mechanisms Involved
Toward a New Psychosomatic Phenotype: The Neuroconnective Phenotype